Florida’s Drug Importation Plan Is Missing Cost Savings, Supply Chain Data, FDA Says

 
• By Brenda Sandburg

Florida says new questions about its proposal show the lengths FDA will go to avoid approving it. FDA extends its deadline for acting on the application, which is the most detailed of four submitted to the agency.

Drug costs
FDA wants more information on cost savings under Florida's proposed prescription drug importation program • Source: Shutterstock (Shutterstock)

More from Pricing Debate

More from Market Access